Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases — San Antonio, Texas

Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases is a clinical research site located in San Antonio, Texas, United States 78229.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Alzheimer Disease, Alzheimer Disease, Early Onset, Mild Cognitive Impairment.

Sponsors: The University of Texas Health Science Center at San Antonio, Karuna Therapeutics, Inc., a Bristol Myers Squibb company.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases?

Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases conducted?

Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases has 4 clinical trials on record, with 2 currently active. Their work covers Alzheimer Disease, Alzheimer Disease, Early Onset, Mild Cognitive Impairment.

Is Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases accredited by Crixeo Health?

Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.